ABT vs. BTSG: Abbott Laboratories vs. BrightSpring Health Services Stock Comparison

Company Profile

Abbott Laboratories (ABT) and BrightSpring Health Services (BTSG) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while BTSG is classified in Health Care Providers & Services.

Abbott Laboratories (ABT) carries decades of public-market history since March 17, 1980, while BrightSpring Health Services (BTSG) listed on January 26, 2024 — long-window comparisons have far more historical data on the ABT side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

BrightSpring Health Services (BTSG) has an aggressive beta of 1.75, indicating higher sensitivity to broad-market moves, while Abbott Laboratories (ABT) is defensive at 0.53 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

BrightSpring Health Services (BTSG) at 15.54% sits in the top ROE quartile, while Abbott Laboratories (ABT) at 9.14% is closer to the peer norm — stronger capital efficiency for BTSG.

Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of BrightSpring Health Services (BTSG) at 2.69%, which keeps about the industry-typical share.

Both Abbott Laboratories (ABT) at 11.66% and BrightSpring Health Services (BTSG) at 3.81% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

BrightSpring Health Services (BTSG) at 28.18% sits in the top revenue growth quartile, while Abbott Laboratories (ABT) at 5.67% is closer to the peer norm — faster top-line expansion for BTSG.

Only one side can be read here: Abbott Laboratories (ABT) reports EPS growth of -51.31%, ranked against its industry; BrightSpring Health Services (BTSG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Both Abbott Laboratories (ABT) at 1.46 and BrightSpring Health Services (BTSG) at 1.62 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Abbott Laboratories (ABT) at 0.61 carries an industry-typical debt-to-equity mix, while BrightSpring Health Services (BTSG) at 1.09 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

BrightSpring Health Services (BTSG) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

BrightSpring Health Services (BTSG) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Abbott Laboratories (ABT) at 41.02 and BrightSpring Health Services (BTSG) at 47.62 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

BrightSpring Health Services (BTSG) at 0.88 sits in the cheaper P/S ratio quartile while Abbott Laboratories (ABT) at 3.95 prices around its industry’s middle — BTSG costs less per dollar of sales, though read it alongside growth and margins.

Abbott Laboratories (ABT) at 3.73 is valued about in line with its industry on P/B ratio, while BrightSpring Health Services (BTSG) at 6.39 carries an above-peer premium to book — BTSG is pricier on assets.

Valuation Metrics